Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
4,612
datasets available to search
ShareScore release 0.9.0
Dataset results
4,612 results for “Labels”
Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443
ClinicalTrials.gov study NCT00631475. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
ClinicalTrials.gov study NCT00788528. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open-label Study to Assess Immunogenicity and Safety of a Vaccine Enhancement Patch When Administered With 2 Doses of H5N1 Vaccine
ClinicalTrials.gov study NCT01353534. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Open-label Study of Neuraminidase Inhibitor Treatment in STEMI Patients
ClinicalTrials.gov study NCT04684498. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open-Label, 2 Treatment Period,Study To Study The Drug Interaction Between Repeated Doses Of Itraconazole And Single Dose Pharmacokinetics (PK) Of PF-06648671 In Healthy Adults.
ClinicalTrials.gov study NCT02883114. IPD Sharing: Not stated. Countries: 1. Publications: 0.
This Will be an Open-label, Three-period, Fixed-sequence Study to Evaluate the Drug-drug Interaction, Pharmacokinetics and Safety of Dutasteride and Tamsulosin When Administered Alone and In-combinati
ClinicalTrials.gov study NCT01957189. IPD Sharing: YES. Countries: 1. Publications: 0.
Open-label Safety Study of Dipraglurant (ADX48621) in Patients With Parkinson's Disease Receiving Levodopa-based Therapy
ClinicalTrials.gov study NCT05116813. IPD Sharing: NO. Countries: 1. Publications: 0.
A Single-arm, Open-label, Multi-center Phase II Clinical Study to Evaluate the Safety and Efficacy of Toripalimab Injection (JS001) Combined With Bevacizumab as the First-line Therapy for Advanced Hep
ClinicalTrials.gov study NCT04605796. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Studying Off Label Insurance Coverage for Patients With Cutaneous Cancers a "Filter" Observational Study
ClinicalTrials.gov study NCT07215988. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open Label Positron Emission Tomography (PET) Study of GSK618334 in Healthy Male Subjects Using 11C-PHNO as PET Ligand
ClinicalTrials.gov study NCT00814957. IPD Sharing: YES. Countries: 1. Publications: 0.
Trifluridine/Tipiracil Plus Fruquintinib vs. Trifluridine/Tipiracil Plus Bevacizumab in Refractory Metastatic Colorectal Cancer: A Randomized, Controlled, Open-Label, Non-Inferiority Trial
ClinicalTrials.gov study NCT07261709. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Open-label, Drug-Drug Interaction With SB_MDZ in Healty Adult Subjects
ClinicalTrials.gov study NCT06846684. IPD Sharing: NO. Countries: 1. Publications: 0.
Open-label Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Auriхim
ClinicalTrials.gov study NCT03057418. IPD Sharing: NO. Countries: 1. Publications: 0.
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
ClinicalTrials.gov study NCT04906460. IPD Sharing: NO. Countries: 3. Publications: 0.
A Clinical Trial to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic People With Schizophrenia, Followed by an Open-label Extension Phase
ClinicalTrials.gov study NCT04825860. IPD Sharing: NO. Countries: 4. Publications: 0.
PhaseII,Open-label,Pilot Study Evaluating the Safety+Efficacy of Certican ® in the Prevention of Chronic Graft-versus-host Disease+Late Pulmonary Complications After Allogeneic Hematopoietic Cell Tran
ClinicalTrials.gov study NCT01509560. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Single-arm, Open-label, Phase II Study to Evaluate Efficacy, Safety and Pharmacokinetics of HLX10 + Chemotherapy in Patients With ES-SCLC
ClinicalTrials.gov study NCT06812260. IPD Sharing: NO. Countries: 1. Publications: 0.
An Open-Label Study of INV-1120 As a Single Agent and in Combination with Pembrolizumab in Adult Patients with Advanced Solid Tumors
ClinicalTrials.gov study NCT04443088. IPD Sharing: NO. Countries: 1. Publications: 0.
A Multicenter, Open Label Phase I Clinical Trial Evaluating the Safety and Pharmacokinetics of TQB2252 Injection in Subjects With Advanced Malignant Tumors
ClinicalTrials.gov study NCT06649656. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors
ClinicalTrials.gov study NCT05074472. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.